Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
11%
OVERLAP
BY WEIGHT
7
# OF OVERLAPPING
HOLDINGS
BBP
63
HOLDINGS
12%
ALSO IN IBRN
IBRN
73
HOLDINGS
14%
ALSO IN BBP
SECTOR DRIFT (BBP minus IBRN)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBP |
Weight in IBRN |
Overlap | |
|---|---|---|---|---|
| AXSOME THERAPEUTICS, INC. | 2.2% | 4.8% | 2.2% | |
| BIOGEN IDEC INC | 1.7% | 3.7% | 1.7% | |
| ARROWHEAD PHARMACEUTICALS, INC. | 1.7% | 4.6% | 1.7% | |
| SAREPTA THERAPEUTICS INC | 1.6% | 2.2% | 1.6% | |
| NEUROCRINE BIOSCIENCES INC | 1.4% | 4.1% | 1.4% | |
BBP Overweight Relative to IBRN
| IMMUNITYBIO INC | 4.8% | |
| APELLIS PHARMACEUTICALS, INC. | 2.6% | |
| KALVISTA PHARMACEUTICALS INC | 2.5% | |
| IOVANCE BIOTHERAPEUTICS INC | 2.5% | |
| MODERNA, INC. | 2.5% | |
| MIRUM PHARMACEUTICALS, INC. | 2.4% | |
| TRAVERE THERAPEUTICS, INC. | 2.0% | |
| ROIVANT SCIENCES LTD. | 2.0% | |
| NOVAVAX INC | 2.0% | |
| BIOCRYST PHARMACEUTICALS INC | 1.9% |
BBP Underweight Relative to IBRN
| ALKERMES PLC | -4.4% | |
| ARGENX SE ADR | -3.9% | |
| SCHOLAR ROCK HOLDING CORP. | -3.6% | |
| CATALYST PHARMACEUTICAL PART | -3.6% | |
| DIANTHUS THERAPEUTICS INC | -3.3% | |
| SUPERNUS PHARMACEUTICALS INC | -3.0% | |
| DENALI THERAPEUTICS INC. | -2.9% | |
| ARROWHEAD PHARMACEUTICALS, INC. | -2.9% | |
| EDGEWISE THERAPEUTICS, INC. | -2.9% | |
| NEUROCRINE BIOSCIENCES INC | -2.8% |